Preliminary Program: Thursday, May 8
7 a.m.-8:30 a.m.
Industry-Supported Breakfast Symposia
7:30 a.m.-2 p.m.
Registration/Course Enrollment Open
8 a.m.-Noon
CME Courses 94-95
9 a.m.-10:30 a.m.
Issue Workshops
IW73. The History of World Psychiatry: Content and ConsequencesChair: Milton Kramer, M.D.
IW74. The Future of Psychiatry: Utilizing a Neurodevelopmental Model for Case FormulationCo-Chairs: Jennifer L. McLaren, M.D., Robert L. Hendren, D.O.
IW75. American Board of Psychiatry and Neurology Update: Certification and Maintenance of Certification in Psychiatry and Its SubspecialtiesChair: Larry R. Faulkner, M.D.
IW76. Developments in the Assessment of Capacity, Statutory Changes, and Administrative Aids: The Road to Less LitigationCo-Chairs: Michael J. Wise, M.D., Julian Beezhold, M.D.
IW77. Controversies in Bipolar Disorder: A Clinical PerspectiveChair: Gary E. Miller, M.D.
IW78. Atherogenic Dyslipidemia in Patients Treated With Atypical AntipsychoticsChair: Peter Manu, M.D.
IW79. Patient Simulation: British and American Adaptations for Psychiatric Education of Medical StudentsCo-Chairs: Julia Z. Frank, M.D., Subodh Dave, M.D.
IW80. Medical Legal Aspects of Psychic Trauma: A Family ApproachCo-Chairs: Michael Hughes, M.D., Jon A. Shaw, M.D.
IW81. Iraq on the Ground: The Real Story Through a Psychiatrist's LensChair: Anita S. Everett, M.D.
IW82. Enhancing the Milieu: Development of a Comprehensive Inpatient Cognitive-Behavior Therapy ProgramCo-Chairs: Katherine L. Lynch, Ph.D., Jean Kim, M.D.
IW83. Second Chance Program: 10 Years of Successfully Treating the Treatment-Refractory Patient With SchizophreniaChair: Adam J. Savitz, M.D.
IW84. Is There a Role for Complementary and Alternative Medicine in the Treatment of Depression?Chair: Meera Narasimhan, M.D.
IW85. Insecurity, Violence, and Trauma in Haiti: Clinical ImplicationsHaitian-American Psychiatric Association; Co-Chairs: Jacques Vital-Herne, M.D., Pierre Jean-Noel, M.D.
IW86. The Clinician's Role Changing the Light BulbCo-Chairs: Marcia Scott, M.D., Paul Pendler, Psy.D.
IW87. Reducing Inpatient Suicide in Kids: Practical Strategies for the Inpatient TeamCo-Chairs: Meena Ramani, M.D., Nyapati R. Rao, M.D.
IW88. Risk Management Issues in Psychiatric PracticeCo-Chairs: Jacqueline M. Melonas, J.D., Martin G. Tracy, J.D.
IW89. Adoption Psychiatrist on the MoveCo-Chairs: Victor J. Buwalda, M.D., Michelle Riba, M.D.
IW90. The Child Psychiatrist as Grandparent: Grand Joys and Grand ChallengesCo-Chairs: Ellen H. Sholevar, M.D., G. Pirooz Sholevar, M.D.
IW91. The Science of Life: The Application of Ayurveda in Mental HealthCo-Chairs: Aravinda Kolan, M.D., Karl Goodkin, M.D.
IW92. Cognitive Dysfunction in Substance Dependence: Types of Deficits and Their Possible ModulationNational Institute on Drug Abuse; Chair: Frank J. Vocci, Ph.D.
IW93. Brain Substrates of Impaired Error Detection, Moral Judgment, and Agency as Core Deficits in Substance AbuseNational Institute on Drug Abuse; Chair: Steven Grant, Ph.D.
IW94. Practitioner Feedback on NIMH's Clinical Treatment TrialsNational Institute of Mental Health; Chair: John K. Hsiao, M.D.
IW95. Primary Care Depression Management: The Design and Implementation of a Focused Acute-Phase Medication Management Quality Improvement ProgramChair: Robert C. Joseph, M.D.
IW96. Insight and Awakening: Mindfulness and PsychotherapyCo-Chairs: Anjali C. Dsouza, M.D., James L. Griffith, M.D.
IW97. Transforming the Local Mental Health System: A Person-Centered ProgramChair: John S. McIntyre, M.D.
IW98. So You Want to Be a Clinical Investigator!Chair: Arthur L. Lazarus, M.D.
IW99. Biopsychosocial and Spiritual Aspects of Treating Our Physician ColleaguesChair: Monisha R. Vasa, M.D.
9 a.m.-Noon
Case Conference 4
Glen Gabbard, M.D., on Psychodynamic Psychotherapy: Erotic Transference and the Female Therapist
(Open to APA members only)
Symposia
S76. Translational Research on Obsessive-Compulsive Disorder
The Utility of Genetic Research to Identify Etiologically Distinct Syndromes Amenable to Advancing Treatment Options Gerald Nestadt, M.D. | |||||
DBS of the Ventral Internal Capsule/Ventral Striatum for OCD: Experience, Effects, and Potential Mechanisms Benjamin D. Greenberg, M.D. | |||||
The Potential and Pitfalls of Animal Models of OCD: A Clinical Perspective Helen Blair Simpson, M.D., Ph.D. | |||||
Targeting Glutamate: Novel Treatment Interventions for OCD Vladimir Coric, M.D. | |||||
S77. Assessing and Reducing Risk of Violence Among People With Schizophrenia and Other Mental Disorders
Schizophrenia and Risk Factors for Community Violence: Does Antipsychotic Treatment Reduce Risk? Jeffrey W. Swanson, Ph.D. | |||||
Violence Risk and Mandated Community Treatment Marvin S. Swartz, M.D. | |||||
Facilitating Treatment Engagement to Lower Risk of Violence Eric B. Elbogen, Ph.D. | |||||
11 a.m.-12:30 p.m.
Advances in Medicine
AM04. Journal RoundupMonique Yohanan, M.D.
Issue Workshops
IW100. Facts About FACT (a Dutch Version of Assertive Community Treatment): Theory, Implementation, Practice, and EvaluationChair: J. Remmers J. van Veldhuizen, M.D.
IW101. Innovations in the Evaluation of Professionals Who Engage in Boundary ViolationsCo-Chairs: Werner Tschan, M.D., Gary R. Schoener, M.A.
IW102. Oral Boards Boot Camp: 2008Co-Chairs: Elyse D. Weiner, M.D., Eric D. Peselow, M.D.
IW103. Responding to the Impact of Suicide on CliniciansChair: Eric M. Plakun, M.D.
IW104. Size Matters: Teaching Medical Students in Small GroupsChair: Kien T. Dang, M.D.
IW105. Where Is the Line Drawn? Is There a Clinical Interface Between Autism Spectrum Disorders and Bipolar Disorder in Children and Adolescents?Chair: Michelle S. Guchereau, M.D.
IW106. Transforming Mental Health Care in South Carolina: A Perspective on Strengthening Partnerships Between Academia and the Department of Mental HealthChair: Richard K. Harding, M.D.
IW107. Children of PsychiatristsCo-Chairs: Michelle B. Riba, M.D., Leah J.Dickstein, M.D.
IW108. Inflammation, Psychosis, and the Brain: What Do We Really Know?Chair: Tatiana Falcone, M.D.
IW109. Stress Response and Women's Health: A Literature Review and Biopsychosocial PerspectiveChair: Lucila Sloninsky, M.D.
IW110. Improving, Interfering, or Inane: Current Lessons From Formal Patient Feedback to PsychiatristsChair: Jacob E. Sperber, M.D.
IW111. My Patient Is Stalking Me: Management of Erotomania in Residency and BeyondChair: Kenneth M. Certa, M.D.
IW112. Application of Cultural Variables for Effective Psychotherapy of the Migrant Asian Population in the United StatesCo-Chairs: Vijoy K. Varma, M.D., Nitin Gupta, M.D.
IW113. Women Serving Life Sentences: Crime, Punishment, and TreatmentCo-Chairs: Sharon S. Snow, Psy.D., Daun H. Martin, Ph.D.
IW114. Addressing Changes in Metabolic Status Associated With Medications for Psychotic and Mood Disorders: Focus on Atypical AntipsychoticsCo-Chairs: Martin Brecher, M.D., Henry A. Nasrallah, M.D.
IW115. Innovative Models for Extending Psychiatric Care to ChildrenChair: Radmila Bogdanich, M.A.
IW116. A Federal Perspective on Reducing Mental Health Disparities: How Can Psychiatry ParticipateSubstance Abuse and Mental Health Services Administration; Co-Chairs: Francis G. Lu, M.D., Larke Huang, Ph.D.
IW117. Psychiatry Training for Primary Care Physicians: An Ongoing ChallengeChair: Hoyle Leigh, M.D.
IW118. Humor and Humans: A New Treatment Modality for Patients With DepressionCo-Chairs: Anna Bokarius, B.A., Waguih W. IsHak, M.D.
Scientific and Clinical Reports Session 27. Psychopharmacology of Schizophrenia
78. Racial Differences in Prescribing Practices in the Treatment of Schizophrenia Karen Bullock, Ph.D.
79. Risperidone Alone Versus Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility Leslie Citrome, M.D.
80. Asenapine in Schizophrenia: An Overview of Clinical Trials in the Olympia Program Steven Potkin, M.D.
Session 28. Attention-Deficit Disorder in Adults
81. Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder Lenard Adler, M.D.
82. Adult Attention-Deficit/Hyperactivity Disorder in an Anxiety Disorders Population Michael Van Ameringen, M.D.
83. Inattention and Hyperactivity Symptoms in Individuals at Risk for Psychosis Juha M. Veijola, Ph.D.
Session 29. Topics in Mood Disorders
84. Patients' Involvement in Treatment Decisions and Antidepressant Discontinuation Stephen Woolley, D.Sc.
85. Prevalence and Characteristics of Bipolar Mixed Depression in STEP-BD Patients Joseph Goldberg, M.D.
86. Depressive Symptoms Predispose Females to Metabolic Syndrome: A Population-Based, Seven-Year Follow-Up Study Hannu Koponen, M.D.
Noon-1:30 p.m.
Forums
9. Grading the State Psychiatric SystemsChair: Anand Pandya, M.D.
10. The Dos and Don'ts of APA SubmissionsChair: Donald Hilty, M.D.
2 p.m.-5 p.m.
Symposia
S78. AIDS Psychiatry in 2008
A Biopsychosocial Approach to AIDS: The 27th Year Mary Ann Cohen, M.D. | |||||
HIV-Associated Sleep Disorders: A Comprehensive Approach Harold W. Goforth, M.D. | |||||
HIV-Associated Neurocognitive Disorders: An Update Steve Ferrando, M.D. | |||||
Update on HIV Treatment in the Severely Mentally Ill Francine Cournos, M.D. | |||||
Psychotherapeutic Issues MarshallForstein, M.D. | |||||
Methamphetamine and HIV Treatment Antoine Douaihy, M.D. | |||||
S79. Religion That Heals, Religion That Harms: What Is the Place of Psychiatry?
When Religion Does Harm: How Do I Respond as a Clinician? James L. Griffith, M.D. | |||||
Killing in the Name of God Jerrold M. Post, M.D. | |||||
Working With the Religious Aspect of Patients' Moral Concerns John Peteet, M.D. | |||||
Cults: Faith, Healing, and Coercion Marc Galanter, M.D. | |||||
S80. Behavioral and Psychological Symptoms of Dementia (BPSD): An Update
Behavioral and Psychological Symptoms of Dementia: An Evidence-Based Review Kirsten M. Wilkins, M.D. | |||||
Inappropriate Sexual Behaviors in Dementia: A Review Karin E. Kerfoot, M.D. | |||||
Risk of Stroke and Death in Elderly Demented Patients Treated With Atypical Antipsychotics: A Review of Published Data Rehan Aziz, M.D. | |||||
S81. Mentalizing as a Framework for Effective Psychotherapy
What Is Distinctive About Mentalizing? Jon G. Allen, Ph.D. | |||||
Mentalization and Developmental Psychopathology Peter Fonagy, Ph.D. | |||||
Promoting Mentalizing in Individual and Group Psychotherapy Anthony W. Bateman, M.D. | |||||
What Does Mentalizing Leave Out? A Cognitive-Behavior Therapist's Perspective Thröstur Björgvinsson, Ph.D. | |||||
S82. Parasomnias, Violence, and the Law
Overview of Parasomnias: A Review for Psychiatric Practice Dimitri Markov, M.D. and Karl Doghramji, M.D. | |||||
Evaluation of Childhood Parasomnias as a Predictor for Future Sleep Violence Nicole Foubister, M.D. | |||||
Sexsomnia: Phenomenology and Forensic Implications Elena delBusto, M.D. | |||||
Sleep Disorders, Violence, and Criminal Responsibility Kenneth J. Weiss, M.D. | |||||
S83. Quality and Outcome Assessment in Diverse Clinical Settings
Is the Effectiveness of Quality Improvement Associated With Organizational Fit? Richard C. Hermann, M.D. | |||||
Health of the Nation Outcome Scales and Questionnaire: Tools for Routine Clinical Outcome Measures for Moderate to Severe Mental Illnesses Victor J. Buwalda, M.D. | |||||
Implementation and Use of Outcome Assessments as Quality Indicators in Long-Term Mental Health Care Annet A. Nugter, Ph.D. | |||||
S84. Pharmacogenetics in Psychiatry
Overview of Genetic and Pharmacogenetic Approaches in Psychiatry Todd Lencz, Ph.D. | |||||
Pharmacogenetics in Bipolar Disorder John R. Kelsoe, M.D. | |||||
Pharmacogenetics of Antidepressants Francis McMahon, M.D. | |||||
Pharmacogenetics of Schizophrenia Anil K. Malhotra, M.D. | |||||
S85. APA's Goldwater Rule: Ethics of Speaking Publicly About Public Figures
Legal Issues Behind the Goldwater Rule Lisa Dagostino, M.D. | |||||
A Prudent and Professional Position Is Often Challenging William Arroyo, M.D. | |||||
The Psychiatrist in the Community: A Broader Ethical Perspective Claire L. Pouncey, M.D. | |||||
When Psychiatrists Speak Out About Public Figures: Legal Liability, Medical Ethics, and Private Conscience Jerome L. Kroll, M.D. | |||||
S86. Neuroethics: Ethical Challenges at the Cutting Edge of Neuroscience
Genes, Blame, Responsibility, and the Brain: Views of Patients Robert L. Klitzman, M.D. | |||||
Ethical Issues in Research on Deep Brain Stimulation for Treatment-Resistant Depression Laura B. Dunn, M.D. | |||||
The New Lie Detectors: Neuroscience in the Courts Paul S. Appelbaum, M.D. | |||||
Determinism and the Death of Folk Psychology: Two Challenges to Responsibility From Neuroscience Stephen J. Morse, J.D. | |||||
Building Better Brains: The Ethics of Neuroenhancement Paul R. Wolpe, Ph.D. | |||||
S87. Indigenous Models of Mind and Mental Health
Indigenous Mental Health With Particular Reference to Akadian and Mikman Cultures Margaret Williams, M.D. | |||||
Mind and Mental Health Within the Mayan Cultures: Comparison With Conventional Psychiatric Models Anne Marie Chaisson, M.D. | |||||
Narrative Philosophy: A Bridge Between Conventional Psychiatry and Aboriginal Idea of Mind and Mental Health Lewis Mehl-Madrona, M.D. | |||||
Models of Mind and Mental Health From the Southeastern U.S.: What Can We Do? Robert Crocker, M.D. | |||||
Huichole Ideas of Mind and Mental Health Bruce W. Scotton, M.D. | |||||
S88. Technologies to Improve Psychotherapy Training and Outcomes
Computer-Assisted Cognitive-Behavior Therapy in Clinical Practice Jesse H. Wright, M.D. | |||||
Simulation-Based Assessment and Training in Psychotherapy Usha Satish, Ph.D. | |||||
Web-Based Learning in Psychotherapy: A Demonstration! Priyanthy Weerasekera, M.D. | |||||
Through the Looking Glass With Supervision: Video Recording 2 John Manring, M.D. | |||||
S89. Children of Immigrants: Developmental and Mental Health Needs
Identity Formation in Children of Immigrants R. Rao Gogineni, M.D. | |||||
Mental Health of Children of Latino Immigrants in the U.S. Andres J. Pumariega, M.D. | |||||
Culture and Identity Development of Asian-Indian Children Aradhana Sood, M.D. | |||||
The Health and Well-Being of Children of Immigrants Randolph Capps, Ph.D. | |||||
S90.DSM-V:From Research to Clinical Issues
Mental Disorder Versus Understandable Mental Suffering: Is the Difference Clear? Is It Relevant to Treatment Decisions? Mario Maj, M.D. | |||||
Public Health Implications of Changing Classification of Mental Disorders Norman Sartorius, M.D. | |||||
Increasing the Validity in DSM-V Roger Peele, M.D. | |||||
S91. Stuck in the Black Box: A Patient Safety Approach to Prescribing Antidepressants
Uses of Genetic Testing John W. Goethe, M.D. | |||||
Making It to Morning: A Resident's Perspective Jason G. Roof, M.D. | |||||
S92. Poverty and Mental Illness Around the World
Poverty, Maternal Depression, and Infant Morbidity in the Developing World: Can the Vicious Circle Be Broken? John L. Cox, M.D. | |||||
The Effects of Poverty on Mental Illness Around the World: The African Perspective Frank G. Njenga, M.D. | |||||
Everyday Emotional Disturbances in Mexican Urban Populations With Low Financial Resources Maria Elena Medina Mora, Psy.D. | |||||
A Pilot Intervention to Promote Mental Health Among Widows of Injecting Drug Users in Northeast India Helen E. Herrman, M.B. | |||||
The High Cost of Poverty: Mental Health Perspectives From the Caribbean Diaspora Frederick W. Hickling, D.M. | |||||
Impact of Poverty on Mental Health in the Middle East Nasser N. Loza, M.D. | |||||
S93. Beyond the Walls: Can Principles of Moral Treatment Be Applied to Contemporary Mental Health Systems?
Echoes of Moral Treatment in the Planetree Movement Virginia L. Susman, M.D. | |||||
Moral Treatment in Contemporary Practice Christopher J. Holman, M.B. | |||||
All Things Old Are New Again: The Impact of Moral Treatment on Contemporary Psychiatry Gregory A. Miller, M.D. | |||||
The Paradox of Moral Treatment in Modern Times Harold I. Schwartz, M.D. | |||||
S94. Hormones, Identities, and Cultures: Clinical Issues in Transgender Youth
Formation of Transgender Identities in Adolescence Richard R. Pleak, M.D. | |||||
Transgender Children: Clinical and Ethical Issues in Prepubertal Presentations Edgardo J. Menvielle, M.D. | |||||
Issues in Working With Female-to-Male Transgender Youth Sarah E. Herbert, M.D. | |||||
African-American and Latino Transgender Youth Vernon A. Rosario, M.D. | |||||
An Endocrine Perspective on the Care of Transgender Adolescents Norman Spack, M.D. | |||||
S95. Impulsive-Compulsive Spectrum Disorders: Recognition and Clinical Management
Impulsive-Compulsive Spectrum Disorders: Diagnostic Issues Eric Hollander, M.D. | |||||
Obsessive-Compulsive Disorder, Its Relationship to Impulsivity, and Available Treatments Dan J. Stein, M.D. | |||||
Body Dysmorphic Disorder Katharine A. Phillips, M.D. | |||||
Update on the Clinical Features and Treatment of Trichotillomania and Pathologic Skin Picking Jon E. Grant, M.D. | |||||
Clinical Advances in Understanding and Treating Impulse-Control Disorders Marc N. Potenza, M.D. | |||||
S96. Psychiatric Emergency Services: Medico-Legal Issues in Crisis Care
Medico-Legal Issues Faced by Psychiatric Emergency Physicians Avrim B. Fishkind, M.D. | |||||
Psychiatric Emergency Services: Medico-Legal Issues in Crisis Care Susan Stefan, J.D. | |||||
Legal Liability Pitfalls in Psychiatric Emergency Care and Practical Suggestions to Avoid Them Steven R. Smith, B.A. | |||||
The Lived Experience of Medico-Legal Issues in ERs Edward L. Knight, Ph.D. | |||||
S97. ADHD Update: Management of New Complexities and Ongoing Challenges
Diagnosis and Treatment of ADHD and Bipolar Spectrum Disorders in Youth Jeffrey H. Newcorn, M.D. | |||||
Neurobiology and Management of Tic Disorders Robert D. Hunt, M.D. | |||||
Minimizing Growth Effects of ADHD Medication in Clinical Practice Christopher Kratochvil, M.D. | |||||
Stimulant Use and Cardiovascular Issues Stephen E. Kimmel, M.D. | |||||
Childhood ADHD and Risk for Adolescent Substance Abuse Illiyan Ivanov, M.D. | |||||
S98. Advances in Diagnosis and Treatment of Frequently Associated Comorbid Conditions in Youth With Pervasive Developmental Disorders
Comorbidity in Asperger's Disorder and High-Functioning Autism Fred R.Volkmar, M.D. | |||||
Genetic Studies of Pervasive Developmental Disorders and Related Disorders of Cognitive Development Eric M. Morrow, M.D. | |||||
Treating Attention-Deficit/Hyperactivity Disorder Symptoms in Pervasive Developmental Disorders David J. Posey, M.D. | |||||
Response to Second-Generation Neuroleptics in Youth With Comorbid Pervasive Developmental Disorders and Bipolar Disorder Gagan Joshi, M.D.▪ | |||||
